Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2009 - 2026)

Johnson & Johnson has disclosed Net Income towards Common Stockholders across 18 years of filings, most recently posting $5.5 billion for Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders changed 0.05% year-over-year to $5.5 billion; the TTM figure through Jun 2026 stood at $21.0 billion (down 7.17% YoY), while the FY2025 annual figure was $26.8 billion, up 90.56% from the prior year.
• Net Income towards Common Stockholders came in at $5.5 billion for Q2 2026 at Johnson & Johnson, up from $5.2 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $26.0 billion in Q4 2023 to a low of -$68.0 million in Q2 2023.
• Average Net Income towards Common Stockholders over 5 years is $5.8 billion, with a median of $4.9 billion recorded in 2022.
• Year-over-year, Net Income towards Common Stockholders plunged 101.34% in 2023 and jumped 4886.76% in 2024.
• Over 5 years, Net Income towards Common Stockholders stood at $4.5 billion in 2022, then retreated by 9.17% to $4.0 billion in 2023, then slipped by 15.26% to $3.4 billion in 2024, then jumped by 49.11% to $5.1 billion in 2025, then increased by 8.17% to $5.5 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $5.5 billion in Q2 2026, $5.2 billion in Q1 2026, and $5.1 billion in Q4 2025.